Baichuan AI
Baichuan Intelligence was founded in April 2023 by former Sogou CEO Wang Xiaochuan. It began with open-source and commercial general-purpose LLMs (Baichuan-7B/13B, Baichuan 2–4). In 2025 it restructured around healthcare, and by 2026 it had narrowed its focus to medical AI, including the Baichuan-M3 and M4 models. Its business model is paid medical-model APIs, hospital partnerships and consumer products such as Baixiaoyi. It has raised roughly $1B in total, including a roughly $691M Series A in July 2024 at about a $2.8B valuation. Wang said in January 2026 that it held about RMB 3B in cash and might consider an IPO in 2027.
Funding
Every round, secondary, debt facility or acquisition involving Baichuan AI that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in